BCBR: 'Bioscience firms to make pitches for VC'

Quoting from the Boulder County Business Report website:

"Boulder County companies and investors feature prominently in the Rocky Mountain Life Science Investor and Partnering Conference slated for Wednesday and Thursday in Denver.

More than 30 bioscience companies from across the Rocky Mountain region will make 15-minute pitches to potential investors at the conference at the Brown Palace Hotel in Denver. Bioscience companies in the region have garnered more than $11.5 billion in financing and acquisition since the end of 2007, according to statistics compiled by the Colorado BioScience Association, an industry trade group."

Link to bcbr.com

Innovative Thought Leaders Address the 2011 Rocky Mountain Life Science Investor Conference in Denver

Three renowned speakers will present the most innovative research, collaborations and partnerships within the bioscience industry today at the Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), Thursday, September 22, at the Brown Palace Hotel in Denver. The announcement is made by Holli Riebel (formerly Baumunk), President and CEO of the Colorado BioScience Association (CBSA), who says: "The conference will be attended by leaders of early-stage private and public life science, bioscience investors and strategic partners."

The RMLIPC is the region’s only bioscience conference of its kind. This year’s speakers will discuss new innovative business models to bring emerging technologies to market and develop partnerships for success. “The keynote presenters are crucial thought leaders shaping the future of the bioscience industry,” Riebel said.

The breakfast keynote on Thursday will feature Peter A. Gottlieb, MD, Professor of Pediatrics and Medicine at the University of Colorado Denver and Center Director at the Barbara Davis Center for Childhood Diabetes, and Dennis R. Roop, Ph.D., Director of The Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology at the University of Colorado Anschutz Medical Campus. According to Riebel, the CBSA is honored to present these two thought leaders in the clinical world and the stem cell research arena. Drs. Gottlieb and Roop will share how they look at research philanthropy as a growing model for creating and sustaining university initiatives, including Centers of Excellence, that address critical research needs and potential commercializable opportunities.

The luncheon keynote will feature Roy Davis, President, Johnson & Johnson Corporate Development. Mr. Davis is a returning expert presenter at the conference and will share his presentation “Strategic Value Creation: A Corporate Investor’s View,” including his vision for new partnering research and development strategies and expert insight into current issues affecting the biotechnology industry.

Link to the Business Wire release

Link to the PitchEngine Social Media Release

w3w3.com Interviews Holli Riebel: 'Challenges and solutions for the Bio and Life Sciences industry'

Quoting from CBSA Pres/CEO's recent interview with w3w3.com's Larry Nelson on the upcoming Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) in Denver:

"The Bio and Life Sciences industry faces huge challenges raising venture capital in a difficult economy. Investing in an industry that takes ten to twelve years and over $1.3 Billion to bring a drug to market just might shift the action to some widget or a software program that can be flipped to realize a return in just six months. That's the challenge facing the Colorado BioScience Association (CBSA) and president/CEO, Holli Riebel. 'Also,' she said, 'venture capitalists reside more on the coasts, and so we're always having a more difficult time attracting venture capital out here in the middle of the country.'"

Link to w3w3.com

Link to download the podcast

Medivance® Inc. Arctic Sun Products are the Preferred Choice of 2011 U.S. News & World Report Top-10 Ranked Honor Roll Hospitals

Louisville, CO, - September 13, 2011 - Building on a track record of serving the nation's top ranked hospitals, Medivance® Inc. is pleased to announce the 2011 U.S. News & World Report's Top-10 Ranked Honor Roll Hospitals are all users of its Targeted Temperature Management™ product, the Arctic Sun®. The announcement was made by Robert Kline, President & CEO, who stated, "It is often said that you are known by the company you keep, and there's no better group of medical centers to be affiliated with than the U.S. News Top-10 Honor Roll. The Medivance Team is very proud of this achievement."

Body temperature, systematically measured and reported as a vital sign, contributes to maintenance of normal physiology and affects the processes leading to recovery after illness. Intentional manipulation of body temperature has therefore emerged as a key treatment strategy for hospitals. The Medivance® Arctic Sun® brings precision Targeted Temperature Management™ to the highest level of performance available today for intentionally manipulating body temperature as a treatment strategy.

"Our Arctic Sun® 5000 is really the only product in the market that can achieve, with precision, a prescribed order set for temperature management with consistency for each patient. This is of particular importance in the hospital environment for Continuous Quality Improvement , thus it's not surprising the top ten Honor Roll hospitals make use of our technology," Kline explained.

Link to the PR Newswire

Link to the PRWeb Newswire

Link to the PitchEngine Social Media Release

9News Interview: "Conference brings together local innovative life-science companies"

CBSA Pres/CEO Holli Reibel interviewed with 9News Business Reporter Gregg Moss this morning about the upcoming Rocky Mountain Life Science Investor and Partnering Conference in Denver. Presenting companies featured in the interview included PeptiVir, VetDC and Flashback Technologies.

Link to information about the RMLIPC, being held Sept 21-22 at the Brown Palace

Link to the related 9News.com posting

CBSA's Pres/CEO Holli Riebel Joins CU Tech Transfer Advisory Board

Quoting from the Boulder County Business Report:

"BOULDER - Eleven new members have been added to the University of Colorado Technology Transfer Office's Business Advisory Board.

The tech transfer office facilitates the movement of CU technologies from the research lab to the marketplace. The Business Advisory Board plays an important part in assessing the tech transfer office's performance, advising on new initiatives, providing access to the technology business community and advocating for resources needed to build a world-class technology transfer operation at CU.

New board members include:

Shannon Golden-Shubert, partner and co-founder at Life + Tech Law.

Doug Henston, renewable energy entrepreneur.

Paul Nelson, managing director at Clean Range Ventures.

Rex R. O'Neal, partner at Faegre & Benson LLP; co-chairman of the firm's emerging companies practice and new energy, clean technology and climate initiative.

Misha Plam, founder of BiOptix and AmideBio.

Holli Riebel, president and chief executive of the Colorado BioScience Association.

John Ryan, partner at medical technology firm Onset Ventures.

Chris Shapard, executive director of the Colorado Cleantech Industry Association.

Laura Simon, director of UC Denver's Office of BioPharma Alliances.

Fintan R. Steele, associate director at CU-Boulder's Colorado Initiative in Molecular Biotechnology.

Trent Yang, director of entrepreneurship and business development at the CU-Boulder Renewable and Sustainable Energy Institute.

Link to bcbr.com

LifeScience Aurora: 'Sen. Michael Bennet, FDA commissioner hold roundtable discussion with CEOs'

Quoting from the new LifeScience Aurora publication:

"The dialogue was what the CBSA needed according to President and CEO Holli Riebel.

'The session today is a positive next step to work CBSA has already contributed to Sen. Bennet’s Coloradoans For An Innovation Economy (CFAIE), and speaks strongly to the work the Senator is doing on our industry’s behalf,' Riebel said in a statement."

Link to the article